Mitoxantrone Loaded Superparamagnetic Nanoparticles for Drug Targeting: A Versatile and Sensitive Method for Quantification of Drug Enrichment in Rabbit Tissues Using HPLC-UV
Table 3
Mitoxantrone (MTO) recovery of pure MTO or MTO bound to ferrofluid (FF) in 2.5 g tissue using a RP-18-Cartridge. 1st section shows extractants based on hydrochloric acid, 2nd section shows phosphoric acid-based extractants, and 3rd section shows phosphate-buffer extractants. In general: FF-bound MTO in liver tissue exhibited insufficient recovery rates.
Cartridge
Matrix
Extraction mode (3)
Condition/Elution-mode
Recovery [%](1)
No cartridge
FF-MTO
1 N HCl
No cartridge
93(2)
Sep-Pak-Plus C18
MTO
1 N HCl
1 N HCl/MeOH
1st
Sep-Pak-Plus C18
MTO + porcine muscle tissue
1 N HCl
H2O/MeOH
Sep-Pak-Plus C18
MTO + porcine liver
1 N HCl
1 N HCl/MeOH
Sep-Pak-Plus C18
FF-MTO
1 N HCl
1 N HCl/MeOH
Sep-Pak-Plus C18
FF-MTO + porcine liver
1 N HCl
1 N HCl/MeOH
No Cartridge
FF-MTO
0.1 M H3PO4
No Cartridge
94(2)
2nd
Sep-Pak-Plus C18
FF-MTO
0.1 M H3PO4
1 N HCl/MeOH
Sep-Pak-Plus C18
MTO + porcine liver
0.1 M H3PO4
0,1 M H3PO4/MeOH
Sep-Pak-Plus C18
FF-MTO + porcine liver
0.1 M H3PO4
MeOH/0, 1 M H3PO4
3rd
Sep-Pak-Plus C18
FF-MTO + porcine liver
0.1 M KH2PO4/H3PO4 (pH = 6.0)
1 N HCl/MeOH
n.d.(4)
Sep-Pak-Plus C18
FF-MTO + porcine liver
0.1 M KH2PO4/HCl
1 N HCl/MeOH
(1)number of independent experiments (2)single experiment (3)Typical extraction procedure: double incubation in ultrasonic bath each for 10 minutes. Collecting the supernatant after centrifugation and HPLC-measurement afterwards (4)Not detectable.